| NDC Code | 0574-0227-01 |
|---|
| Package Description | 100 TABLET in 1 BOTTLE (0574-0227-01) |
|---|
| Product NDC | 0574-0227 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Benazepril Hydrochloride And Hydrochlorothiazide |
|---|
| Non-Proprietary Name | Benazepril Hydrochloride And Hydrochlorothiazide |
|---|
| Dosage Form | TABLET |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190407 |
|---|
| End Marketing Date | 20251231 |
|---|
| Marketing Category Name | NDA AUTHORIZED GENERIC |
|---|
| Application Number | NDA020033 |
|---|
| Manufacturer | Padagis US LLC |
|---|
| Substance Name | BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE |
|---|
| Strength | 10; 12.5 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS] |
|---|